L&C BIO Co.,LTD (KOSDAQ:290650)

L&C BIO Co.,LTD Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	7,753	18,287	14,949	6,592	17,382	22,266
Short-Term Investments	-0	4,599	40,183	4,000	-	-
Trading Asset Securities	6,347	1,252	4,060	1,725	2,238	5,078
Cash & Short-Term Investments	14,099	24,137	59,193	12,316	19,620	27,344
Cash Growth	-73.11%	-59.22%	380.60%	-37.23%	-28.25%	-5.42%
Accounts Receivable	21,121	21,735	18,223	13,193	12,718	9,104
Other Receivables	470.97	29,725	911.84	220.48	153.76	202.61
Receivables	21,992	52,049	19,894	13,553	13,242	9,306
Inventory	47,456	46,779	46,288	34,203	12,312	8,085
Prepaid Expenses	-	1,997	1,598	82.37	800	67.25
Other Current Assets	6,342	5,093	3,384	4,129	1,659	698.07
Total Current Assets	89,889	130,056	130,357	64,284	47,632	45,501
Property, Plant & Equipment	95,263	97,017	74,655	53,138	17,895	9,483
Long-Term Investments	28,511	28,547	45,546	73,626	34,966	20,679
Goodwill	197,307	197,307	-	2,320	-	-
Other Intangible Assets	2,235	1,932	1,456	1,255	1,150	215.27
Long-Term Accounts Receivable	-	-	-	-	-	0
Long-Term Deferred Tax Assets	9,048	8,792	-	-	-	89.07
Other Long-Term Assets	8,601	6,429	4,346	4,102	5,058	4,609
Total Assets	432,053	475,601	262,230	199,725	107,401	80,576
Accounts Payable	-	2,331	1,745	2,910	1,021	266.24
Accrued Expenses	-	815.93	467.84	331.95	163.99	136.58
Short-Term Debt	32,536	98,436	79,154	9,508	-	-
Current Portion of Long-Term Debt	67,003	166.56	166.56	166.56	125.56	-
Current Portion of Leases	-	1,260	1,396	967.16	607.2	370.16
Current Income Taxes Payable	177.08	203.55	13,460	759.14	699.92	248.62
Current Unearned Revenue	-	20.83	20.99	0.15	-	25.67
Other Current Liabilities	12,894	51,317	5,428	4,096	3,017	2,628
Total Current Liabilities	112,610	154,551	101,838	18,738	5,635	3,675
Long-Term Debt	20,023	20,065	541.32	70,565	5,445	13,937
Long-Term Leases	-	3,973	876.13	738.05	652.85	726.04
Long-Term Deferred Tax Liabilities	63.09	63.09	899.75	591.67	1,194	-
Other Long-Term Liabilities	4,359	766.8	396.37	305.91	139.15	89.97
Total Liabilities	138,713	180,876	105,375	91,904	14,136	19,323
Common Stock	11,388	11,388	11,388	11,388	11,388	10,985
Additional Paid-In Capital	33,438	53,438	53,427	51,988	43,875	30,369
Retained Earnings	240,635	222,197	83,593	36,865	33,342	20,639
Treasury Stock	-3,873	-3,873	-3,890	-6,358	-6,358	-4,310
Comprehensive Income & Other	1,715	1,203	2,427	4,069	2,773	124.45
Total Common Equity	283,303	284,353	146,945	97,952	85,021	57,806
Minority Interest	10,037	10,372	9,911	9,869	8,245	3,446
Shareholders' Equity	293,340	294,726	156,856	107,821	93,265	61,253
Total Liabilities & Equity	432,053	475,601	262,230	199,725	107,401	80,576
Total Debt	119,563	123,900	82,134	81,945	6,831	15,033
Net Cash (Debt)	-105,463	-99,763	-22,942	-69,628	12,789	12,311
Net Cash Growth	-	-	-	-	3.88%	-54.61%
Net Cash Per Share	-4186.53	-3960.24	-927.97	-3069.36	573.56	562.26
Filing Date Shares Outstanding	22.68	22.68	22.68	22.68	22.68	21.88
Total Common Shares Outstanding	22.68	22.68	22.68	22.68	22.68	21.88
Working Capital	-22,722	-24,495	28,519	45,546	41,998	41,826
Book Value Per Share	12488.61	12534.92	6477.65	4317.94	3747.89	2642.34
Tangible Book Value	83,761	85,115	145,489	94,377	83,871	57,591
Tangible Book Value Per Share	3692.35	3752.05	6413.47	4160.33	3697.20	2632.50
Land	53,358	53,560	54,556	34,116	2,744	1,265
Buildings	23,213	22,606	7,457	7,457	6,312	3,401
Machinery	17,543	17,514	14,542	12,287	8,773	4,841

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.